spot_img

about fansalaran

FanSalaran is a comprehensive media platform dedicated to reporting and clarifying the significant achievements of pharmaceutical companies. In collaboration with passionate and motivated young journalists, this website consistently strives to showcase the country's successes in order to inspire and encourage the hardworking individuals of this land.

Tag: Novo Nordisk

Novo Nordisk, United Biotechnology obesity drug trial shows 19.7% weight loss

Novo Nordisk said on Tuesday its ‌triple agonist UBT251 of ‌the receptors for GLP-1, GIP and glucagon, jointly developed...

Novo’s Wegovy pill hits over 18,000 US prescriptions in strong debut week

Novo Nordisk's (NOVOb.CO), opens new tab Wegovy pill was prescribed more than 18,000 times in the U.S. in the...

Novo Nordisk, Pfizer sweeten bid for Metsera as bidding war heats up

Novo Nordisk and Pfizer have revised their bids for Metsera, the obesity drug developer said on Tuesday. Novo's revised offer...

Novo Nordisk, Eli Lilly shares drop as Trump vows weight-loss drug price cuts

Shares of weight-loss drug makers Novo Nordisk and Eli Lilly fell on Friday after U.S. President Donald Trump said...

Danish drugmakers jump as Eli Lilly’s weight-loss pill data disappoints

Shares in Novo Nordisk rose as much as 14% on Thursday after trial data from Eli Lilly's experimental weight-loss...